Taken together, the results demonstrated that a high level of CCL3 activates p38 signalling, resulting in the suppression of transcription factor GATA1 expression and blocking erythroid differentiation of CD34+ HSPCs in the MM bone marrow microenvironment. The gene discussed is GATA1; the disease is Miyoshi myopathy.